Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

466 indexed citations
published 2020

Countries where authors are citing Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

Specialization
Citations

This map shows the geographic impact of Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy more than expected).

Fields of papers citing Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy.

About Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

This paper, published in 2020, received 466 indexed citations . Written by Yufeng Liu, Yuan Cheng, Min Zhou, Yijun Yu, Shichao Lin, Bo Jiang, Xiaozhi Zhao, Leiying Miao, Chuan‐Wan Wei and Quanyi Liu covering the research area of Materials Chemistry and Biomedical Engineering. It is primarily cited by scholars working on Materials Chemistry (357 citations), Biomedical Engineering (220 citations) and Molecular Biology (152 citations). Published in Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1126/sciadv.abb2695.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026